🔴 Ardelyx is trading 5% down today amid a broad biotech and market selloff

Ardelyx is trading at $3.12, down 5.02%, amid a sharp risk-off session across the broader market and biotech sector.

• The Nasdaq fell 4.35% and biotech ETF XBI fell 5.19%; a November 5 report described biotech shares tracking a sector selloff.
• No clearly linked company-specific catalyst surfaced for November 5.
• Ardelyx’s November 3 results beat earnings expectations, and its November 4 close rose 8.58%.